Abstract
Clostridium difficile, the causative agent of nosocomial antibiotic-associated diarrhoea and pseudomembranous colitis, possesses two main virulence factors: the large clostridial cytotoxins A and B. It has been proposed that toxin B is cleaved by a cytosolic factor of the eukaryotic target cell during its cellular uptake. Here we report that cleavage of not only toxin B, but also all other large clostridial cytotoxins, is an autocatalytic process dependent on host cytosolic inositolphosphate cofactors. A covalent inhibitor of aspartate proteases, 1,2-epoxy-3-(p-nitrophenoxy)propane, completely blocked toxin B function on cultured cells and was used to identify its catalytically active protease site. To our knowledge this is the first report on a bacterial toxin that uses eukaryotic signals for induced autoproteolysis to deliver its toxic domain into the cytosol of target cells. On the basis of our data, we present an integrated model for the uptake and inositolphosphate-induced activation of toxin B.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tenover, F. C. Mechanisms of antimicrobial resistance in bacteria. Am. J. Infect. Control 34, S3–S10 (2006)
Fishman, N. Antimicrobial stewardship. Am. J. Infect. Control 34, S55–S63 (2006)
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L. & Onderdonk, A. B. Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. N. Engl. J. Med. 298, 531–534 (1978)
George, R. H. et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br. Med. J. 1, 695 (1978)
Gorbach, S. L. Antibiotics and Clostridium difficile. N. Engl. J. Med. 341, 1690–1691 (1999)
Davey, P. et al. Systematic review of antimicrobial drug prescribing in hospitals. Emerg. Infect. Dis. 12, 211–216 (2006)
Lyerly, D. M., Krivan, H. C. & Wilkins, T. D. Clostridium difficile: its disease and toxins. Clin. Microbiol. Rev. 1, 1–18 (1988)
Voth, D. E. & Ballard, J. D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247–263 (2005)
Eichel-Streiber, C., Laufenberg-Feldmann, R., Sartingen, S., Schulze, J. & Sauerborn, M. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol. Gen. Genet. 233, 260–268 (1992)
Green, G. A., Schue, V. & Monteil, H. Cloning and characterization of the cytotoxin L-encoding gene of Clostridium sordellii: homology with Clostridium difficile cytotoxin B. Gene 161, 57–61 (1995)
Hofmann, F., Herrmann, A., Habermann, E. & Eichel-Streiber, C. Sequencing and analysis of the gene encoding the α-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile. Mol. Gen. Genet. 247, 670–679 (1995)
Eichel-Streiber, C., Boquet, P., Sauerborn, M. & Thelestam, M. Large clostridial cytotoxins—a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol. 4, 375–382 (1996)
Rupnik, M. et al. Revised nomenclature of Clostridium difficile toxins and associated genes. J. Med. Microbiol. 54, 113–117 (2005)
Loo, V. G. et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353, 2442–2449 (2005)
McDonald, L. C. et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353, 2433–2441 (2005)
Centers for Disease Control and Prevention (CDC) Severe Clostridium difficile-associated disease in populations previously at low risk—four states, 2005. Morb. Mortal. Wkly Rep. 54, 1201–1205 (2005)
Kuijper, E. J., Coignard, B. & Tull, P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. 12, (Suppl. 6)2–18 (2006)
McDonald, L. C. Clostridium difficile: responding to a new threat from an old enemy. Infect. Control Hosp. Epidemiol. 26, 672–675 (2005)
Eichel-Streiber, C., Sauerborn, M. & Kuramitsu, H. K. Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases. J. Bacteriol. 174, 6707–6710 (1992)
Pfeifer, G. et al. Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J. Biol. Chem. 278, 44535–44541 (2003)
Hofmann, F., Busch, C., Prepens, U., Just, I. & Aktories, K. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem. 272, 11074–11078 (1997)
Tucker, K. D. & Wilkins, T. D. Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect. Immun. 59, 73–78 (1991)
Karlsson, K. A. Microbial recognition of target-cell glycoconjugates. Curr. Opin. Struct. Biol. 5, 622–635 (1995)
Florin, I. & Thelestam, M. Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts. Biochim. Biophys. Acta 763, 383–392 (1983)
Florin, I. & Thelestam, M. Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microb. Pathog. 1, 373–385 (1986)
Henriques, B., Florin, I. & Thelestam, M. Cellular internalisation of Clostridium difficile toxin A. Microb. Pathog. 2, 455–463 (1987)
Giesemann, T. et al. Cholesterol-dependent pore formation of Clostridium difficile toxin A. J. Biol. Chem. 281, 10808–10815 (2006)
Qa'Dan, M., Spyres, L. M. & Ballard, J. D. pH-induced conformational changes in Clostridium difficile toxin B. Infect. Immun. 68, 2470–2474 (2000)
Rupnik, M. et al. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151, 199–208 (2005)
Sehr, P. et al. Glucosylation and ADP ribosylation of Rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry 37, 5296–5304 (1998)
Just, I. et al. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375, 500–503 (1995)
Moos, M. & Eichel-Streiber, C. Purification and evaluation of large clostridial cytotoxins that inhibit small GTPases of Rho and Ras subfamilies. Methods Enzymol. 325, 114–125 (2000)
Hsu, F. F., Turk, J. & Gross, M. L. Structural distinction among inositol phosphate isomers using high-energy and low-energy collisional-activated dissociation tandem mass spectrometry with electrospray ionization. J. Mass Spectrom. 38, 447–457 (2003)
Fernandez-Patron, C., Hardy, E., Sosa, A., Seoane, J. & Castellanos, L. Double staining of Coomassie blue-stained polyacrylamide gels by imidazole-sodium dodecyl sulfate-zinc reverse staining: sensitive detection of Coomassie blue-undetected proteins. Anal. Biochem. 224, 263–269 (1995)
Shears, S. B. Assessing the omnipotence of inositol hexakisphosphate. Cell. Signal. 13, 151–158 (2001)
Saiardi, A., Bhandari, R., Resnick, A. C., Snowman, A. M. & Snyder, S. H. Phosphorylation of proteins by inositol pyrophosphates. Science 306, 2101–2105 (2004)
Sauerborn, M., Hegenbarth, S., Laufenberg-Feldmann, R., Leukel, P. & von Eichel-Streiber, C. Monoclonal antibodies discriminating between Clostridium difficile toxins A and B. Int. J. Med. Microbiol. 24, (Suppl.)510–511 (1994)
Sebaihia, M. et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nature Genet. 38, 779–786 (2006)
Rao, M. B., Tanksale, A. M., Ghatge, M. S. & Deshpande, V. V. Molecular and biotechnological aspects of microbial proteases. Microbiol. Mol. Biol. Rev. 62, 597–635 (1998)
Just, I. & Gerhard, R. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol. 152, 23–47 (2004)
Barth, H. et al. Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J. Biol. Chem. 276, 10670–10676 (2001)
Macbeth, M. R. et al. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 309, 1534–1539 (2005)
Byrum, J., Jordan, S., Safrany, S. T. & Rodgers, W. Visualization of inositol phosphate-dependent mobility of Ku: depletion of the DNA-PK cofactor InsP6 inhibits Ku mobility. Nucleic Acids Res. 32, 2776–2784 (2004)
York, J. D., Guo, S., Odom, A. R., Spiegelberg, B. D. & Stolz, L. E. An expanded view of inositol signaling. Adv. Enzyme Regul. 41, 57–71 (2001)
Braun, V. & von Eichel-Streiber, C. Virulence-associated mobile elements in Bacilli and Clostridia. In Pathogenicity Islands and Other Mobile Elements (American Society of Microbiology, Washington DC, 1999)
Braun, V., Hundsberger, T., Leukel, P., Sauerborn, M. & Eichel-Streiber, C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181, 29–38 (1996)
Acknowledgements
We thank H. Müller, J. Forsch, A. Malotta, N. Robertz and E. Scholz for technical assistance; M. Moos, C. Srokowski and C. Tertilt for critically discussing the manuscript; and A. Lange for his advice in affinity purification of TcdB. Special thanks to M. Popoff for providing C. sordellii TcsL of high quality. This work was supported by grants from the Stiftung Innovation Rheinland-Pfalz and Deutsche Forschungs Gemeinschaft (to C.v.E.-S.). S.T. and H.S. were supported by the Sonderforschungsbereich ‘Invasion und Persistenz bei Infektionen’, the Hochschulbauförderungsgesetz Program (H.S.), and the Immunology Cluster of Excellence (ICE) at the University of Mainz (H.S.). M.R. was supported by an EMBO grant. C.v.E.-S. acknowledges the support of the University of Mainz for offering additional laboratory space in the Verfügungsgebäude für Forschung und Entwicklung.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Table 1, Supplementary Figures 1-5 with Legends and Supplementary Discussion (PDF 951 kb)
Rights and permissions
About this article
Cite this article
Reineke, J., Tenzer, S., Rupnik, M. et al. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446, 415–419 (2007). https://doi.org/10.1038/nature05622
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature05622
This article is cited by
-
Molecular basis of TMPRSS2 recognition by Paeniclostridium sordellii hemorrhagic toxin
Nature Communications (2024)
-
From signal transduction to protein toxins—a narrative review about milestones on the research route of C. difficile toxins
Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
-
Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics
Nature Reviews Microbiology (2022)
-
Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition
Scientific Reports (2022)
-
Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
Nature Communications (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.